Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer

Virus Research

Volumn 93, Issue 1, 2003, Pages 25-30

  Song, Jae Jin ^b   Lee, Boyoung ^a   Chang, Jin Woo ^c   Kim, Joo Hang ^b   Kwon, Yunhee Kim ^d   Lee, Heuiran ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Cytotoxicity; FIV based vector; Gag; Transduction efficiency; Vif

Indexed keywords

GAG PROTEIN; RETROVIRUS VECTOR; VIF PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA VECTOR; EXPRESSION VECTOR; FELINE IMMUNODEFICIENCY VIRUS; GENE TECHNOLOGY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT PLASMID; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS PARTICLE; VIRUS RECOMBINANT;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0242585347     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(03)00047-9     Document Type: Article

References (30)

1. Amado R.G., Chen I.S.Y. Lentiviral vectors - the promise of gene therapy within reach. Science. 285:1999;674-676.
2. Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA. 90:1993;8033-8037.
3. Chang L.J., Gay E.E. The molecular genetics of lentiviral vectors - current and future perspectives. Curr. Gene Ther. 1:2001;237-251.
4. Coffin J.M. Retroviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1984;1767-1848 Lipponcott-Raven Press, New York.
5. Curran M.A., Kaiser S.M., Achacoso P.L., Nolan G.P. Efficient transduction of nondividing cells by optimized deline immunodeficiency virus vectors. Mol. Ther. 1:2000;31-38.
6. Fenyo E.M., Morfeldt-Manson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., Asjo B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:1998;4414-4419.
7. Hopkins N. High titers of retrovirus (vesicular stomatitis virus) pseudotypes. Proc. Natl. Acad. Sci. USA. 90:1993;8759-8760.
8. Johnston J., Power C. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J. Virol. 73:1999;2491-2498.
9. Johnston J.C., Gasm M., Lim L.E., Elder J.H., Yee J.K., Jolly D.J., Campbell K.P., Davidson B.L., Sauter S.L. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73:1999;4991-5000.
10. Lee H., Song J.J., Kim E., Yun C.O., Choi J., Lee B., Kim J., Chang J.W., Kim J.H. Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor. Gene Ther. 8:2001;268-273.
11. Lever A.M. Lentiviral vectors: progress and potential. Curr. Opin. Mol. Ther. 82:2000;488-496.
12. Lockridge K.M., Himathongkham S., Sawai E.T., Chienand M., Sparger E.E. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology. 261:1999;25-30.
13. Miyazawa T., Tomonaga K., Kawaguchi Y., Mikami T. The genome of feline immunodeficiency virus. Arch. Virol. 134:1994;221-234.
14. Parseval A., Elder J.H. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial Rev activity. J. Virol. 73:1999;608-617.
15. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 235:1987;790-793.
16. Phillips T.R., Lamont C., Konings D.A., Shacklett B.L., Hamson C.A., Luciw P.A., Elder J.H. Identification of the rev transactivation and rev-responsive elements of feline immunodeficiency virus. J. Virol. 66:1992;5464-5471.
17. Poeschla E.M., Flossie W.-S., Looney D.J. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4:1998;354-357.
18. Sakai K., Ma X.Y., Gordienko I., Volsky D.J. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. J. Virol. 65:1991;5765-5773.
19. Shacklett B.L., Luciw P.A. Analysis of the vif gene of feline immunodeficiency virus. Virology. 204:1994;860-867.
20. Song J.J., Kim J.-H., Lee H., Kim E., Kim J., Park Y.S., Ahn J., Yoo N.-C., Roh J.K., Kim B.S. Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals. Oncol. Rep. 7:2000;119-124.
21. Steinwaerder D.S., Carlson C.A., Lieber A. DNA replication of first-generation adenovirus vectors in tumor cells. Hum. Gene Ther. 11:2000;1933-1948.
22. Tochikura T.S., Hayes K.A., Cheney C.M., Tanabe-Tochikur A., Rojko J.L., Mathes L.E., Olsen R.G. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells. Virology. 179:1990;492-497.
23. Tomonaga K., Mikami T. Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen.Virol. 77:1996;1611-1621.
24. Tomonaga K., Norimine J., Shin Y.S., Fukasawa M., Miyazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., Mikami T.I. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66:1992;6181-6185.
25. Tomonaga K., Miyazawa T., Sakuragi J., Mori T., Adachi A., Mikami T. The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes. J. Virol. 67:1993;5889-5895.
26. Tomonaga K., Shin Y.S., Fukasawa M., Miyazawa T., Adachi A., Mikami T. Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and the monocistronic rev mRNA. J. Gen. Virol. 74:1993;2409-2417.
27. Tomonaga K., Miyazawa T., Kawaguchi Y., Kohmoto M., Inoshima Y., Mikami T. Comparison of the rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J. Vet. Med. Sci. 56:1994;199-201.
28. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7:2000;20-23.
29. Waters A.K., De Parseval A.P., Lerner D.L., Nei J.C., Thompson F.J., Elder J.H. Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology. 215:1996;10-16.
30. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA. 91:1994;9564-9568.